Wikisage, the free encyclopedia of the second generation, is digital heritage

Zimeldine: Difference between revisions

From Wikisage
Jump to navigation Jump to search
No edit summary
 
Line 1: Line 1:
While zilmelidine had a very favorable safety profile, within a year and a half of its introduction, rare case reports of Guillain–Barré syndrome emerged that appeared to be caused by the drug, prompting its manufacturer to withdraw it from the market
While zilmelidine had a very favorable safety profile, within a year and a half of its introduction, rare case reports of [[Guillain–Barré syndrome]] emerged that appeared to be caused by the drug, prompting its manufacturer to withdraw it from the market
==Links==
==Links==
[https://karmel.miraheze.org/w/index.php?title=Zimeldina&oldid=8535 Karmel(miraheze)]
[https://karmel.miraheze.org/w/index.php?title=Zimeldina&oldid=8535 Karmel(miraheze)]


{{Wikidata|Q203483}}
{{Wikidata|Q203483}}

Latest revision as of 14:24, 21 March 2019

While zilmelidine had a very favorable safety profile, within a year and a half of its introduction, rare case reports of Guillain–Barré syndrome emerged that appeared to be caused by the drug, prompting its manufacturer to withdraw it from the market

Links

Karmel(miraheze)

Q203483 at Wikidata  Interwiki via Wikidata